Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
DOR off and running on news of collaboration with US Army. Now at .70 +25% in pm. Jim
TSRG made it to .028 on 4th try today. Over 37 million traded. Now at .0295 + 64%. JIm
RWNT up 15% to .0047. 19million traded. Worth keeping an eye on. Jim
There was some good volume in GZFX as it hit .15, but that dried up fast. Now at .155 + 7%. 6.5 million traded so far. Jim
GZFX has big volume coming in now. PPS up to .15 + 3% after being down all morning. Jim
TSRG has attacked .028 three times so far. A few trades at that amount, with many at .0275. Sliding back again here. Maybe another shake? We shall see. Just took my sell off. Was trying for .029. Figure now if it moves up again that .03's are coming. Otherwise guess I will be just a stuckholder. Over 15 million traded so far. Now up 44% to .026. Jim
TSRG has attacked .028 three times so far. A few trades at that amount, with many at .0275. Sliding back again here. Maybe another shake? We shall see. Just took my sell off. Was trying for .029. Figure now if it moves up again that .03's are coming. Otherwise guess I will be just a stuckholder. Over 15 million traded so far. Jim
TSRG now at .024. It is really going now. Jim
TSRG continue up on high volume. Now at .023 +28%. Jim
TSRG does look good this morning. Good volume and pps now at .021 +17%. Jim
TSRG off well on good volume. Now at .02 +11%. Jim
Maybe the purpose of that lame PR is to get the price lower for the 'planned' buyback. LOL. Jim
Most going at .001 now. Looks like a very good day for CMKX, but not much left until more news. Hope it stays at .001 or above at the close.
Jim
QBID now up to .014 + 9%. Good volume too. Now at 65 million. Jim
QBID trying to keep up with its partner CMKX today. Now up to .014 + 9%. Good volume too. Now at 65 million. Jim
BSDM volume is now 43 times average. Now up 23% to 1.60. Jim
BSDM - volume 25 X average and the most since last October. No pps movement. Interesting? This one is way undervalued. Jim
TSRG b/a just moved up to .014/.016 and some volume is coming in. May be time for it to resume uptrend. Jim
RWNT good volume again. Ready to pop as most if not all S8 shares should be gone after yesterday's 41 million day. Now at .005 +11%. 5.4 million traded so far. Jim
ICGE continues big move the last 2 weeks. Now at 7.05 +.37 for today and 2.25 since reverse. Jim
RCO - well the .27's are gone. 1.25 million shares at that price the last 10 minutes. 1 million now on the bid at .27 and 350K on ask of .28. This is it? Jim
VRA - 3 million shares on the bid at .16. May be ready? Jim
VRA - 3 million shares on the bid at .16. May be ready? Jim
AVR may get a boost from new distribitor news. Wednesday June 9, 8:30 am ET
Switzerland's Morwell Diagnostics Selects Avitar's ORALscreen(TM) On-site Drugs-of-Abuse Test For Distribution
CANTON, Mass., June 9 /PRNewswire-FirstCall/-- Avitar, Inc. (Amex: AVR - News) announced today that it is adding Morwell Diagnostics GmbH of Switzerland to its growing list of international distribution partners, now spanning Australia, Canada, Croatia, Hungary, Malaysia, Mexico, and Thailand.
"As a result of our strong experience in drugs-of-abuse testing, we know that technical product quality, reliability and support are critical selection criteria in our search for an oral-based on-site screen for drugs-of-abuse," explained Dr. E. Moradian, Managing Director of Morwell Diagnostics, GmbH. "We also highly value the continuing advancement of technology and product range. Our extensive research led us to select Avitar and the ORALscreen(TM) instant oral-based drug test, and we believe the decision will help our organization maintain a leadership position."
Dr. Moridian further noted, "The benefits of on-site drug testing are understood in Switzerland. For example, in the justice system, on-site oral testing allows drug screening to be done in the presence of individuals without the added costs of external laboratories, or the inherent risk of adulteration common with unsupervised urine collections. In schools, oral testing is a superior alternative to observed urine collection. Oral tests preserve the student's dignity, and maintain appropriate student- administration relationships."
"We are very pleased to have a market leader of Morwell Diagnostics' caliber represent Avitar. Their reputation for quality and service is well known throughout Switzerland, represent Avitar solutions," noted Pete Phildius, President & CEO of Avitar. "Our relationship with Morwell further demonstrates that Avitar's oral on-site drugs-of-abuse products are gaining acceptance on a world wide basis."
Morwell Diagnostics offers a wide range of laboratory services including lab-based urine testing. Although urine testing is well established in Switzerland, saliva testing is gaining ground, especially in non-medical settings where collection of urine is either not possible, difficult, or in settings where urine samples may be easily adulterated. A simple saliva sample collected in the presence of an officer or test administrator is preferable in these cases. The benefits of oral testing, increased hygiene and the avoidance of uncomfortable situations related to sample collection with a person in attendance, present Morwell Diagnostics with an excellent complement to the company's existing drugs-of-abuse testing products and services.
ABOUT AVITAR
Avitar, Inc. develops, manufactures and markets innovative and proprietary products in the oral fluid diagnostic market and customized polyurethane applications used in the wound dressing industry. Oral fluid diagnostics includes the estimated $1.5 billion drugs-of-abuse testing market, which encompasses the corporate workplace and criminal justice markets. Avitar's products include ORALscreen(TM), the world's first non-invasive, rapid, onsite oral fluid test for drugs-of-abuse. Additionally, Avitar manufactures and markets HYDRASORB(TM), an absorbent topical dressing for moderate to heavy exudating wounds. For more information, see Avitar's website at http://www.avitarinc.com.
ABOUT Morwell Diagnostics GmbH
Morwell Diagnostics is a leading supplier of medical diagnostic and research reagents in Switzerland. Located just outside Z/rich and a short distance from the airport, Morwell's modern facilities are fully equipped to deliver quality products to multiple market sectors. The facilities include extensive cool rooms, quality control and technical support laboratories, a manufacturing facility for immunological products, as well as technically advanced sales and marketing offices.
Safe Harbor Statement. This release contains forward looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the Company's filings with the Securities and Exchange Commission. In view of such risks and uncertainties, the Company's actual results could differ materially from those anticipated in such forward looking statements.
Contact:
Peter N. Cholakis
Vice President, Marketing
(781) 821-2440 x117
pcholakis@avitarinc.com
www.avitarinc.com
--------------------------------------------------------------------------------
Source: Avitar, Inc.
AVR up in pm on news. Wednesday June 9, 8:30 am ET
Switzerland's Morwell Diagnostics Selects Avitar's ORALscreen(TM) On-site Drugs-of-Abuse Test For Distribution
CANTON, Mass., June 9 /PRNewswire-FirstCall/-- Avitar, Inc. (Amex: AVR - News) announced today that it is adding Morwell Diagnostics GmbH of Switzerland to its growing list of international distribution partners, now spanning Australia, Canada, Croatia, Hungary, Malaysia, Mexico, and Thailand.
"As a result of our strong experience in drugs-of-abuse testing, we know that technical product quality, reliability and support are critical selection criteria in our search for an oral-based on-site screen for drugs-of-abuse," explained Dr. E. Moradian, Managing Director of Morwell Diagnostics, GmbH. "We also highly value the continuing advancement of technology and product range. Our extensive research led us to select Avitar and the ORALscreen(TM) instant oral-based drug test, and we believe the decision will help our organization maintain a leadership position."
Dr. Moridian further noted, "The benefits of on-site drug testing are understood in Switzerland. For example, in the justice system, on-site oral testing allows drug screening to be done in the presence of individuals without the added costs of external laboratories, or the inherent risk of adulteration common with unsupervised urine collections. In schools, oral testing is a superior alternative to observed urine collection. Oral tests preserve the student's dignity, and maintain appropriate student- administration relationships."
"We are very pleased to have a market leader of Morwell Diagnostics' caliber represent Avitar. Their reputation for quality and service is well known throughout Switzerland, represent Avitar solutions," noted Pete Phildius, President & CEO of Avitar. "Our relationship with Morwell further demonstrates that Avitar's oral on-site drugs-of-abuse products are gaining acceptance on a world wide basis."
Morwell Diagnostics offers a wide range of laboratory services including lab-based urine testing. Although urine testing is well established in Switzerland, saliva testing is gaining ground, especially in non-medical settings where collection of urine is either not possible, difficult, or in settings where urine samples may be easily adulterated. A simple saliva sample collected in the presence of an officer or test administrator is preferable in these cases. The benefits of oral testing, increased hygiene and the avoidance of uncomfortable situations related to sample collection with a person in attendance, present Morwell Diagnostics with an excellent complement to the company's existing drugs-of-abuse testing products and services.
ABOUT AVITAR
Avitar, Inc. develops, manufactures and markets innovative and proprietary products in the oral fluid diagnostic market and customized polyurethane applications used in the wound dressing industry. Oral fluid diagnostics includes the estimated $1.5 billion drugs-of-abuse testing market, which encompasses the corporate workplace and criminal justice markets. Avitar's products include ORALscreen(TM), the world's first non-invasive, rapid, onsite oral fluid test for drugs-of-abuse. Additionally, Avitar manufactures and markets HYDRASORB(TM), an absorbent topical dressing for moderate to heavy exudating wounds. For more information, see Avitar's website at http://www.avitarinc.com.
ABOUT Morwell Diagnostics GmbH
Morwell Diagnostics is a leading supplier of medical diagnostic and research reagents in Switzerland. Located just outside Z/rich and a short distance from the airport, Morwell's modern facilities are fully equipped to deliver quality products to multiple market sectors. The facilities include extensive cool rooms, quality control and technical support laboratories, a manufacturing facility for immunological products, as well as technically advanced sales and marketing offices.
Safe Harbor Statement. This release contains forward looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the Company's filings with the Securities and Exchange Commission. In view of such risks and uncertainties, the Company's actual results could differ materially from those anticipated in such forward looking statements.
Contact:
Peter N. Cholakis
Vice President, Marketing
(781) 821-2440 x117
pcholakis@avitarinc.com
www.avitarinc.com
--------------------------------------------------------------------------------
Source: Avitar, Inc.
GZFX made the .12 barrier finally. Been in the .10/.11 area for a while. New web site up next Monday and 'Dell Dude' commercials start a few days later. This one should be a good trader the next 2 weeks. Just went to .125. 5 million traded today. Jim
TTGG - thanks Buzz. Will give it a whirl here at current levels. Jim
ICGE - No more 'D' for ICGE. The move up has been strong and steady. Another .80 added so far today. Now at 6.88. That's 2.08 since the the reverse. Jim
ICGE - No more 'D' for ICGE. The move up has been strong and steady. Another .80 added so far today. Now at 6.88. That's 2.08 since the the reverse. Jim
RWNT - Dream agree. RWNT hod at .0054. Now at .0053. Huge volume last hour. For the day at 25 million shares traded. Jim
QBID - Maybe promised contract news is on the way? Up 10% to .0134. Jim
RWNT hod at .0054. Now at .005. Huge volume last hour. For the day at 24 million shares traded. Jim
RWNT continues the volume spike. 15 million traded so far. PPS is at .0054 a hod. Don't be fooled by what looks like a down day. Close yesterday was skewed by 3 low volume trades at .006 and .007 after really finishing at around .004. Jim
RWNT continues the volume spike. 15 million traded so far. PPS is at .0054 a hod. Don't be fooled by what looks like a down day. Close yesterday was skewed by 3 low volume trades at .006 and .007 after really finishing at around .004. Jim
RWNT volume spike last few minutes. Lod is .0041. Now at hod of .005. Jim
RWNT volume spike last few minutes. Lod is .0041. Back to .0049. Jim
MCLD now up 8% to .79. Good volume. Jim
RWNT - coming off the floor here. Back to .0045 from lod at .0036. This one has taken quite a hit lately. Should have a nice bounce left in it. Jim
RWNT - coming off the floor here. Back to .0045 from lod at .0036. This one has taken quite a hit lately. Should have a nice bounce left in it. Jim
RCO - Has moved up steadily the last two weeks from bottom .18. Now at .28 with good volume. Jim